241 related articles for article (PubMed ID: 21357694)
1. Novel role of base excision repair in mediating cisplatin cytotoxicity.
Kothandapani A; Dangeti VS; Brown AR; Banze LA; Wang XH; Sobol RW; Patrick SM
J Biol Chem; 2011 Apr; 286(16):14564-74. PubMed ID: 21357694
[TBL] [Abstract][Full Text] [Related]
2. Differential role of base excision repair proteins in mediating cisplatin cytotoxicity.
Sawant A; Floyd AM; Dangeti M; Lei W; Sobol RW; Patrick SM
DNA Repair (Amst); 2017 Mar; 51():46-59. PubMed ID: 28110804
[TBL] [Abstract][Full Text] [Related]
3. Epistatic role of base excision repair and mismatch repair pathways in mediating cisplatin cytotoxicity.
Kothandapani A; Sawant A; Dangeti VS; Sobol RW; Patrick SM
Nucleic Acids Res; 2013 Aug; 41(15):7332-43. PubMed ID: 23761438
[TBL] [Abstract][Full Text] [Related]
4. Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis.
Enoiu M; Jiricny J; Schärer OD
Nucleic Acids Res; 2012 Oct; 40(18):8953-64. PubMed ID: 22810206
[TBL] [Abstract][Full Text] [Related]
5. Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin.
De Silva IU; McHugh PJ; Clingen PH; Hartley JA
Nucleic Acids Res; 2002 Sep; 30(17):3848-56. PubMed ID: 12202770
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
[TBL] [Abstract][Full Text] [Related]
7. Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links.
Sawant A; Kothandapani A; Zhitkovich A; Sobol RW; Patrick SM
DNA Repair (Amst); 2015 Nov; 35():126-36. PubMed ID: 26519826
[TBL] [Abstract][Full Text] [Related]
8. Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair.
Bulgar AD; Weeks LD; Miao Y; Yang S; Xu Y; Guo C; Markowitz S; Oleinick N; Gerson SL; Liu L
Cell Death Dis; 2012 Jan; 3(1):e252. PubMed ID: 22237209
[TBL] [Abstract][Full Text] [Related]
9. Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway.
Zhang N; Liu X; Li L; Legerski R
DNA Repair (Amst); 2007 Nov; 6(11):1670-8. PubMed ID: 17669695
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression.
Usanova S; Piée-Staffa A; Sied U; Thomale J; Schneider A; Kaina B; Köberle B
Mol Cancer; 2010 Sep; 9():248. PubMed ID: 20846399
[TBL] [Abstract][Full Text] [Related]
11. Base excision repair enzymes protect abasic sites in duplex DNA from interstrand cross-links.
Admiraal SJ; O'Brien PJ
Biochemistry; 2015 Mar; 54(9):1849-57. PubMed ID: 25679877
[TBL] [Abstract][Full Text] [Related]
12. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.
Arora S; Heyza J; Zhang H; Kalman-Maltese V; Tillison K; Floyd AM; Chalfin EM; Bepler G; Patrick SM
Oncotarget; 2016 Nov; 7(46):75104-75117. PubMed ID: 27650543
[TBL] [Abstract][Full Text] [Related]
13. Evidence for different mechanisms of 'unhooking' for melphalan and cisplatin-induced DNA interstrand cross-links in vitro and in clinical acquired resistant tumour samples.
Spanswick VJ; Lowe HL; Newton C; Bingham JP; Bagnobianchi A; Kiakos K; Craddock C; Ledermann JA; Hochhauser D; Hartley JA
BMC Cancer; 2012 Sep; 12():436. PubMed ID: 23020514
[TBL] [Abstract][Full Text] [Related]
14. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
Pérez C; Leng M; Malinge JM
Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
[TBL] [Abstract][Full Text] [Related]
15. The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites.
Raetz AG; Banda DM; Ma X; Xu G; Rajavel AN; McKibbin PL; Lebrilla CB; David SS
J Biol Chem; 2020 Mar; 295(11):3692-3707. PubMed ID: 32001618
[TBL] [Abstract][Full Text] [Related]
16. HPV induction of APOBEC3 enzymes mediate overall survival and response to cisplatin in head and neck cancer.
Conner KL; Shaik AN; Ekinci E; Kim S; Ruterbusch JJ; Cote ML; Patrick SM
DNA Repair (Amst); 2020 Mar; 87():102802. PubMed ID: 31981740
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine potentiates cisplatin cytotoxicity and inhibits repair of cisplatin-DNA damage in ovarian cancer cell lines.
Moufarij MA; Phillips DR; Cullinane C
Mol Pharmacol; 2003 Apr; 63(4):862-9. PubMed ID: 12644587
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3 enzymes mediate efficacy of cisplatin and are epistatic with base excision repair and mismatch repair in platinum response.
Conner KL; Shaik AN; Marshall KA; Floyd AM; Ekinci E; Lindquist J; Sawant A; Lei W; Adolph MB; Chelico L; Siriwardena SU; Bhagwat A; Kim S; Cote ML; Patrick SM
NAR Cancer; 2020 Dec; 2(4):zcaa033. PubMed ID: 33196045
[TBL] [Abstract][Full Text] [Related]
19. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
Zhu G; Myint M; Ang WH; Song L; Lippard SJ
Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
[TBL] [Abstract][Full Text] [Related]
20. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
Clingen PH; Arlett CF; Hartley JA; Parris CN
Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
